Bin Cao

Title: The Innovations of Bin Cao

Introduction

Bin Cao is an accomplished inventor based in Bedminster, NJ (US). He holds a total of 3 patents that contribute significantly to the field of pharmaceuticals. His work primarily focuses on developing compounds that target various central nervous system disorders.

Latest Patents

One of his latest patents is titled "Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof." This invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically targeting modulators of metabotropic glutamate receptors (mGluR), particularly the mGluR2 receptor. The compounds developed through this invention are useful as pharmaceutical agents in treating a variety of central nervous system disorders, including neurodegenerative conditions, anxiety, depression, and sleep disorders.

Another significant patent is "2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists." This invention focuses on a compound that can treat patients suffering from PGD2-mediated disorders, such as allergic diseases and chronic inflammatory conditions. The pharmaceutical composition developed includes a pharmaceutically effective amount of the compound, which can be administered to patients for effective treatment.

Career Highlights

Throughout his career, Bin Cao has worked with notable companies in the pharmaceutical industry, including Aventis Pharmaceuticals Inc. and Sanofi. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Bin Cao has collaborated with esteemed colleagues, including Keith John Harris and Sungtaek Lim. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Bin Cao's innovative contributions to pharmaceutical inventions demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological systems and a dedication to improving patient outcomes.